Astellas Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ALPMY and buy or sell other stocks, ETFs, and their options commission-free!About ALPMY
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF.
CEONaoki Okamura
CEONaoki Okamura
Employees13,643
Employees13,643
HeadquartersTokyo, Tokyo
HeadquartersTokyo, Tokyo
Founded1923
Founded1923
Employees13,643
Employees13,643
ALPMY Key Statistics
Market cap23.31B
Market cap23.31B
Price-Earnings ratio26.89
Price-Earnings ratio26.89
Dividend yield3.14%
Dividend yield3.14%
Average volume94.74K
Average volume94.74K
High today$12.90
High today$12.90
Low today$12.82
Low today$12.82
Open price$12.82
Open price$12.82
Volume5.40K
Volume5.40K
52 Week high$13.07
52 Week high$13.07
52 Week low$8.37
52 Week low$8.37
Stock Snapshot
Astellas Pharma(ALPMY) stock is priced at $12.88, giving the company a market capitalization of 23.31B. It carries a P/E multiple of 26.89 and pays a dividend yield of 3.1%.
On 2025-12-06, Astellas Pharma(ALPMY) stock traded between a low of $12.82 and a high of $12.90. Shares are currently priced at $12.88, which is +0.5% above the low and -0.2% below the high.
The Astellas Pharma(ALPMY)'s current trading volume is 5.4K, compared to an average daily volume of 94.74K.
During the past year, Astellas Pharma(ALPMY) stock moved between $8.37 at its lowest and $13.07 at its peak.
During the past year, Astellas Pharma(ALPMY) stock moved between $8.37 at its lowest and $13.07 at its peak.
Analyst ratings
62%
of 13 ratingsBuy
30.8%
Hold
61.5%
Sell
7.7%